Following a motor vehicle collision, an unconscious client is admitted to the emergency department (ED) via ambulance. Vital signs on arrival are heart rate 100 beats/minute, respirations 16 breaths/minute, and blood pressure 130/76 mm Hg. The nurse plans to monitor the client for complications associated with a basilar skull fracture. Which finding confirms this complication?

Rationale:
A. Administer an antipyretic agent: The client has a mild fever (100°F), but fever is not the priority concern in the context of hypotension, tachycardia, and low urine output. Treating the fever will not address potential hypovolemia or shock.

B. Titrate IV vasopressor for systolic less than 80: Vasopressors are indicated for persistent hypotension unresponsive to fluid resuscitation. The client’s systolic BP is 88 mm Hg, so initial management should focus on restoring intravascular volume before starting vasopressors.

C. Place a cooling blanket on the client: Cooling measures are used for high fevers. The client’s temperature is only mildly elevated, and addressing fluid status takes priority over lowering temperature at this stage.

D. Give a 500 mL IV fluid bolus challenge: Hypotension, tachycardia, and oliguria indicate possible hypovolemic or distributive shock postoperatively. Administering a fluid bolus helps restore intravascular volume, improve perfusion, and increase urine output, making it the most urgent intervention.

Rationale:

• Cardiogenic shock: The client presents with hypotension, tachycardia, altered mental status, cool clammy skin, oliguria, and severe hypoxia, all of which indicate inadequate tissue perfusion. Echocardiography confirms severe mitral regurgitation with ventricular dilation, leading to poor forward cardiac output. Elevated cardiac markers and atrial fibrillation with rapid ventricular response further compromise cardiac function.

• Heart failure (HF): Although the client has signs of heart failure, including dyspnea, edema, and crackles, the presence of hypotension and end-organ hypoperfusion indicates progression beyond simple heart failure. Cardiogenic shock represents a severe complication of heart failure with systemic consequences. The unstable vital signs and altered mental status support shock physiology. Therefore, heart failure alone does not fully explain the severity of findings.

• Myocardial infarction (MI): Elevated troponins suggest myocardial injury but do not confirm an acute MI as the primary condition. The clinical picture is dominated by pump failure rather than coronary occlusion. Severe mitral regurgitation and ventricular dilation explain the cardiogenic shock more directly. MI may be contributory but is not the primary condition.

• Hypertrophic cardiomyopathy (HCM): HCM typically presents with diastolic dysfunction, preserved systolic function, and a systolic murmur that increases with decreased preload. This client instead shows ventricular dilation and severe mitral regurgitation on echocardiogram. The hemodynamic collapse and volume overload are inconsistent with HCM pathology.

• Administer dopamine: Dopamine at low to moderate doses supports cardiac output by improving myocardial contractility and maintaining blood pressure. The client’s hypotension and signs of poor perfusion make vasoactive support essential. Dopamine helps preserve end-organ perfusion while definitive surgical intervention is planned.

• Administer morphine: Morphine reduces preload and afterload by promoting venodilation, which decreases pulmonary congestion and myocardial oxygen demand. It also relieves severe chest pain and anxiety, both of which increase sympathetic stimulation and worsen cardiac workload. In cardiogenic shock with pulmonary congestion, morphine can improve breathing comfort. Pain control also supports hemodynamic stability.

• Place client on reverse isolation: Reverse isolation is used to protect immunocompromised clients, not those experiencing cardiogenic shock. There is no evidence of neutropenia or infection risk requiring isolation. This intervention would not address perfusion or oxygenation issues. Priority interventions should focus on hemodynamic support.

• Insert nasogastric tube (NGT): An NGT is not indicated in cardiogenic shock unless there is bowel obstruction or severe gastric distention. The client’s hypoactive bowel sounds reflect hypoperfusion, not a gastrointestinal obstruction. Inserting an NGT would not improve cardiac output or oxygenation.

• Transfer client to a cardiac specialty facility: While advanced care is needed, the client is already receiving specialty-level interventions including invasive monitoring and surgical preparation. Immediate stabilization takes priority over transfer logistics. The focus is maintaining perfusion while preparing for mitral valve replacement.

• Urinary output: Urinary output is a sensitive indicator of renal perfusion and overall cardiac output. The client has had no urine output, signaling severe hypoperfusion. Monitoring output allows the nurse to evaluate response to inotropes and fluid management. Improvement suggests better tissue perfusion and stabilization.

• Respiratory rate: An elevated respiratory rate reflects hypoxia and pulmonary congestion caused by left-sided cardiac failure. Monitoring respirations helps assess oxygenation status and response to interventions such as morphine and oxygen therapy. Decreasing tachypnea indicates improved pulmonary circulation and gas exchange.

• Sulfate sensitivity: There is no indication of medication allergy or hypersensitivity reactions. Monitoring sulfate sensitivity is unrelated to the client’s cardiovascular instability. This parameter does not provide information about cardiac output or perfusion.

• Neck vein distention: Neck vein distention reflects volume overload and elevated central venous pressure but does not adequately assess improvement in shock state. While present, it is less useful for tracking response to therapy than urine output or respiratory status. Shock management focuses on perfusion rather than static volume indicators.

• Angioedema: Angioedema is associated with allergic reactions and airway compromise, which are not evident in this case. There is no facial swelling or airway involvement reported. Monitoring for angioedema would not help assess cardiogenic shock progression.